New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AVEO;ODP;RAD;AMAT;NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
09:01 EDTODPOffice Depot stores now accept Apple Pay
Subscribe for More Information
October 16, 2014
09:32 EDTODPOffice Depot: European restructuring plan includes reduction of 1,100 positions
Subscribe for More Information
07:54 EDTAMATApplied Materials weakness creates buying opportunity, says Stifel
Stifel believes that Applied Materials' (AMAT) fundamental story has not changed, while the weakness in the shares is an overreaction to certain issues, including the Microchip (MCHP) preannouncement. Stifel expects the company to benefit from strong WFE spending in 2015 and increasing capital intensity trends in the chip sector. The firm keeps a $25 price target and Buy rating on the shares.
October 15, 2014
10:02 EDTAMATOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTNAVBOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTNAVBNavidea names Gonzalez CEO
Subscribe for More Information
08:01 EDTNAVBNavidea names Gonzalez CEO
07:39 EDTAMATApplied Materials upgraded at BofA/Merrill
Subscribe for More Information
07:03 EDTNAVBNavidea announces FDA sNDA approval for Lymphoseek extended use
Navidea Biopharmaceuticals announced that the U.S. Food and Drug Administration has approved the Supplemental New Drug Application for the expanded use of Lymphoseek injection for lymphatic mapping in solid tumors and adding Sentinel Lymph Node detection for breast cancer and melanoma to the approved indications. The FDA also allowed expanded utilization of Lymphoseek with or without scintigraphic imaging to enable pre-operative imaging and mapping of lymph nodes to facilitate node localization during surgical procedures. Lymphoseek will be immediately available using existing reimbursement codes for this expanded population of cancer patients. In the approval action letter, the FDA also outlined a post-marketing requirement for initiation of a pediatric study in solid tumor cancer with a target date for submission in 2018.
06:15 EDTAMATApplied Materials upgraded to Buy from Neutral at BofA/Merrill
06:08 EDTAMATApplied Materials implied volatility of 47 at upper end of index mean range
Subscribe for More Information
October 13, 2014
10:08 EDTRADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:47 EDTRADRite Aid initiated with a Market Perform at Cowen
Subscribe for More Information
October 10, 2014
11:27 EDTAMATApplied Materials falls with peers, bearish double top active
Subscribe for More Information
11:13 EDTAMATMicrochip not relevant to DRAM, NAND, says Summit Research
Subscribe for More Information
October 8, 2014
10:00 EDTAMATOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADTRAN (ADTN) upgraded to Buy from Neutral at Goldman... Applied Materials (AMAT) upgraded to Outperform from Underperform at CLSA... Bill Barrett (BBG) upgraded to Neutral from Underperform at Macquarie... CNOOC (CEO) upgraded to Buy from Hold at Jefferies... Calamos (CLMS) upgraded to Market Perform from Underperform at Keefe Bruyette... Calix (CALX) upgraded to Buy from Neutral at Goldman... Cimarex Energy (XEC) upgraded to Outperform from Neutral at Macquarie... Cogent (CCOI) upgraded to Outperform from Market Perform at Raymond James... Coty (COTY) upgraded to Neutral from Sell at B. Riley... Dassault Systemes (DASTY) upgraded to Equal Weight from Underweight at Barclays... EOG Resources (EOG) upgraded to Outperform from Neutral at Macquarie... Glu Mobile (GLUU) upgraded to Buy from Hold at Benchmark Co.... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Goodrich Petroleum (GDP) upgraded to Neutral from Underperform at Macquarie... Greif (GEF) upgraded at Wells Fargo... PHH Corp. (PHH) upgraded to Outperform from Market Perform at Keefe Bruyette... Parsley Energy (PE) upgraded to Outperform from Neutral at Macquarie... Rent-A-Center (RCII) upgraded to Buy from Neutral at Northcoast... Royal Gold (RGLD) upgraded to Overweight from Underweight at HSBC... Rush Enterprises (RUSHA) upgraded to Strong Buy at Raymond James... Sanchez Energy (SN) upgraded to Outperform from Neutral at Macquarie... Springleaf (LEAF) upgraded to Outperform from Neutral at Macquarie... TC PipeLines (TCP) upgraded to Neutral from Underweight at JPMorgan... Tesco (TSCDY) upgraded to Neutral from Underweight at HSBC... Vocera (VCRA) upgraded to Outperform at FBR Capital.
07:50 EDTAMAT, AMATApplied Materials upgraded to Outperform from Underperform at CLSA
CLSA upgraded Applied Materials to Outperform and said Tokyo Electron deal concerns are overdone and the company will not go through with the deal if it turns out to be dilutive. Additionally, CLSA said Applied Materials will benefit from the 2015 14/16nm FinFET capex cycle. Price target raised to $23 from $22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use